|
Treatment of
Helicobacter pylori Infection
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and
Figures
Table 1:
Indications for
Testing for Helicobacter pylori Infection
Table
2:
Antimicrobial Activity of Bismuth and Antisecretory Agents
Used In Treating Peptic Ulcer Against Helicobacter pylori
Table
3:
Comparison of
Antimicrobial Susceptibility
Table
4:
Monotherapy Antibiotic
Efficacy in the Eradication of Helicobacter pylori Infection
Table 5:
Drugs
Commonly Used for Treatment of Helicobacter pylori Infection
Table
6:
Regimens for Treatment of Helicobacter pylori Infection
Figure 1: Effect of frequency of H. pylori
in a population on the predictive value of a positive or negative test.
Figure 2: Age related incidence (per
100,000/year) of different cancers among men in the United States
Vignettes
Patterson C.
Nobel Prize Recognizes
Research Tying H. pylori to Ulcers. ASM News 2005, Volume
71, p.563-4.
Berger
S.
Emergence of Infectious Diseases into the
21st Century, 2008.
Chey WD, Wong BCY and the Practice Parameters Committee of the American College
of Gastroenterology.
American College of Gastroenterology Guideline on the
Management of Helicobacter pylori infection. Am J
Gastroenterol 2007;102:1-18.
Gisbert JP, Calvet X, et al.
Sequential Therapy for Helicobacter pylori Eradication: A
Critical Review. J Clin Gastroenterol. 2010 Jan 5. [Epub ahead of
print]
Mege JL, Meghari S, Honstettre A, Capo
C, Raoult D.
The Two faces of interleukin 10 in human infectious
diseases. Lancet Infectious Diseases 2006:7;557-569.
Zullo A, et al.
The sequential therapy regimen for Helicobacter pylori
eradication. Gut 2007.
Vaira D, et al.
How
to proceed in Helicobacter pylori-positive chronic gastritis refractory to
first- and second-line eradication therapy. Dig Dis
2007;25:203-205.
Gram stain,
2008
Authors
Akiko Shiotani, M.D., Ph.D.,
David Y. Graham, M.D.
First
Edition (1998): Mae F. Go and David Y. Graham
|
www.antimicrobe.org